| Application no. and date | 11710087.5 (espacenet) (Federated) (European Patent Register), 20110311 | | Patent/reg. no. and date | DK/EP 2552906, 20160106 | | Publication date | 20130206 | | Priority no. and date | US 319015 P, 20100330 | | EP pub. no. and date |
EP 2552906 20130206 | | Effective date | | | Applicant/owner | Bristol-Myers Squibb Company, Route 206 and Province Line Road
Princeton, NJ 08543, US | | Applicant ref. no. | V134605DK | | Inventor | MACOR, John E., c/o Bristol-Myers Squibb Company
5 Research Parkway
Wallingford, Connecticut 06492, US,
CHATURVEDULA, Prasad V., c/o Bristol-Myers Squibb Company
5 Research Parkway
Wallingford, Connecticut 06492, US,
DUBOWCHIK, Gene M., c/o Bristol-Myers Squibb Company
5 Research Parkway
Wallingford, Connecticut 06492, US | | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | | Opponent | | | IPC Class | A61K 31/496 (2006.01) , A61P 29/00 (2006.01) , C07D 401/14 (2006.01) | | Title | CGRP-RECEPTORANTAGONIST | | Int. application no. | US2011028168 | | Int. publication no. | WO2011123232 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
